Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313651305> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4313651305 endingPage "S2" @default.
- W4313651305 startingPage "S1" @default.
- W4313651305 abstract "Objective To clarify if NK and NKT cells are activated via complement in NMOSD. Background Inhibition of terminal complement in NMOSD using eculizumab has been shown to be helpful in preventing relapses but exactly how the drug is working is not clear. Similarly, genetic variants in the Fc Gamma receptor 3A are correlated with outcomes in NMOSD but the immune cells expressing those FcGR3A receptors are unknown. We compared FcGR3A expression on immune cells modulated by complement activity in NK cells and NKT cells in NMOSD to disease controls and healthy people. Design/Methods Peripheral blood cell (PBMC) samples from 45 patients with NMOSD with AQP4-IgG, 18 disease controls, and 19 normal controls were analyzed for FcGR3A expression and complement receptors in vitro. Results At baseline, the number of NKT cells were increased in NMOSD (p < 0.001), but the proportion that were FcGR3A positive was lower compared to healthy and disease controls (p = 0.0012). NK cell count was normal at baseline but also but the proportion that were FcGR3A positive was also relatively lower (p < 0.001). In both NK cells and NKT cells from NMOSD, C5 complement receptor expression was much higher compared to healthy and disease controls (p < 0.001 for both). We also evaluated activation markers CD69 and CD83, which were also much higher in NK and NKT cells from NMOSD patients. Conclusions Our results support a model of immunopathogenesis model in which complement pathway activation in NK/NKT cells upregulate FcGR3A expression that bind to antibody/antigen complexes. In the context of NMOSD, these complement-sensitive cells may be responsible for escalating autoimmune activity." @default.
- W4313651305 created "2023-01-07" @default.
- W4313651305 creator A5007576002 @default.
- W4313651305 creator A5026541269 @default.
- W4313651305 creator A5036502710 @default.
- W4313651305 creator A5056912783 @default.
- W4313651305 creator A5077228556 @default.
- W4313651305 date "2022-12-05" @default.
- W4313651305 modified "2023-10-14" @default.
- W4313651305 title "Upregulated Complement Receptors Correlate With Fc Gamma Receptor 3A-Positive Natural Killer Cells (NK) and Natural Killer-T Cells (NKT) in Neuromyelitis Optica Spectrum Disorder" @default.
- W4313651305 doi "https://doi.org/10.1212/01.wnl.0000903056.59789.7a" @default.
- W4313651305 hasPublicationYear "2022" @default.
- W4313651305 type Work @default.
- W4313651305 citedByCount "0" @default.
- W4313651305 crossrefType "journal-article" @default.
- W4313651305 hasAuthorship W4313651305A5007576002 @default.
- W4313651305 hasAuthorship W4313651305A5026541269 @default.
- W4313651305 hasAuthorship W4313651305A5036502710 @default.
- W4313651305 hasAuthorship W4313651305A5056912783 @default.
- W4313651305 hasAuthorship W4313651305A5077228556 @default.
- W4313651305 hasBestOaLocation W43136513051 @default.
- W4313651305 hasConcept C111684460 @default.
- W4313651305 hasConcept C126322002 @default.
- W4313651305 hasConcept C139563560 @default.
- W4313651305 hasConcept C159654299 @default.
- W4313651305 hasConcept C170493617 @default.
- W4313651305 hasConcept C175773311 @default.
- W4313651305 hasConcept C203014093 @default.
- W4313651305 hasConcept C2776090121 @default.
- W4313651305 hasConcept C71924100 @default.
- W4313651305 hasConcept C8891405 @default.
- W4313651305 hasConceptScore W4313651305C111684460 @default.
- W4313651305 hasConceptScore W4313651305C126322002 @default.
- W4313651305 hasConceptScore W4313651305C139563560 @default.
- W4313651305 hasConceptScore W4313651305C159654299 @default.
- W4313651305 hasConceptScore W4313651305C170493617 @default.
- W4313651305 hasConceptScore W4313651305C175773311 @default.
- W4313651305 hasConceptScore W4313651305C203014093 @default.
- W4313651305 hasConceptScore W4313651305C2776090121 @default.
- W4313651305 hasConceptScore W4313651305C71924100 @default.
- W4313651305 hasConceptScore W4313651305C8891405 @default.
- W4313651305 hasIssue "23" @default.
- W4313651305 hasLocation W43136513051 @default.
- W4313651305 hasOpenAccess W4313651305 @default.
- W4313651305 hasPrimaryLocation W43136513051 @default.
- W4313651305 hasRelatedWork W2071181996 @default.
- W4313651305 hasRelatedWork W208907758 @default.
- W4313651305 hasRelatedWork W2149706167 @default.
- W4313651305 hasRelatedWork W2408839386 @default.
- W4313651305 hasRelatedWork W2414728851 @default.
- W4313651305 hasRelatedWork W2745272743 @default.
- W4313651305 hasRelatedWork W3029207509 @default.
- W4313651305 hasRelatedWork W3030206206 @default.
- W4313651305 hasRelatedWork W4229796216 @default.
- W4313651305 hasRelatedWork W4230751166 @default.
- W4313651305 hasVolume "99" @default.
- W4313651305 isParatext "false" @default.
- W4313651305 isRetracted "false" @default.
- W4313651305 workType "article" @default.